Advisory Board April 18, 2024
A minimally invasive weight-loss surgery called endoscopic sleeve gastroplasty (ESG) is more effective and less expensive than weight-loss drugs like Wegovy and Ozempic, according to a recent study published in JAMA Network Open.
3 missteps in our approach to treating obesity (and 5 ways to fix it)
Study details
For the study, researchers compared the effectiveness and cost of semaglutide, the main ingredient in weight-loss drugs like Wegovy and Ozempic, and ESG as treatments for obesity within the American healthcare system.
The researchers simulated three groups of middle-aged patients with obesity who either received semaglutide, ESG, or no treatment at all, and looked at weight changes and healthcare costs over the course of five years.
Based on previous research, the...
Today's Sponsors
Today's Sponsor